Nimodipine Capsules 30 mg — Class II drug recall D-003-2013
Terminated recall by Caraco Pharmaceutical Laboratories Ltd., reported 2012-10-10, distributed in MI. Crystallization: Presence of crystals of Nimodipine within the capsule solution.
| Recall number | D-003-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Caraco Pharmaceutical Laboratories Ltd., Cranbury, NJ, United States |
| Recall initiated | 2012-08-21 |
| Classified | 2012-10-03 |
| Reported by FDA | 2012-10-10 |
| Terminated | 2013-11-19 |
| Distributed | MI |
| NDC | 57664-0135-64, 57664-0135-65 |
Product
Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.
Reason for recall
Crystallization: Presence of crystals of Nimodipine within the capsule solution.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-003-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.